ClinicalTrials.gg
RecruitingNCT07002411HOSPERUpdated Jun 3, 2025

Hospitality Oriented Service Perception Evolution With Robots (HOSPER)

An interventional study of Innovative hospital reception service with social robot NAO and Innovative hospital reception service with social robot PEPPER in Quality of Hospital Entrance Reception and Social Robots, sponsored by Istituto Nazionale di Ricovero e Cura per Anziani. Recruiting at 1 site in Italy. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-06-03.

Sponsored by Istituto Nazionale di Ricovero e Cura per Anziani · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Dec 2024, registered May 2025).
  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The HOSPER project aims to determine if using Pepper and NAO social robots at the IRCCS INRCA in Ancona's (Italy) entrance is a viable way to improve the current reception and guidance services for hospital visitors. The robots will offer proactive assistance and directions to departments.

Read the detailed description

The primary aim of the "HOSPER" project is to assess the feasibility of an innovative reception and proactive guidance service designed to enhance the quality of the existing service provided by the IRCCS INRCA in Ancona (Italy). This will be achieved through the deployment of two social robots, Pepper and NAO, located at the hospital entrance to provide information to users inquiring about directions to specific departments. Furthermore, the study will evaluate the level of participant satisfaction with their interactions with the robots.

02

Conditions studied

  • Quality of Hospital Entrance Reception
  • Social Robots

Keywords

  • Older people
03

In context

Lead sponsor

Istituto Nazionale di Ricovero e Cura per Anziani is the lead sponsor of 42 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Possession of full cognitive capacity;

Exclusion criteria

Exclusion Criteria:

    • Lack of written
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    ARM 1

    Older subjects attending the INRCA hospital entrance

    Other: Innovative hospital reception service with social robot NAO

  • Active comparator
    ARM 2

    Older subjects attending the INRCA hospital entrance

    Other: Innovative hospital reception service with social robot PEPPER

Interventions

  • OtherInnovative hospital reception service with social robot NAO

    The robot NAO welcomes the user and asks how it can assist them. At this point, the user responds, and the robot, in turn, replies in two possible ways: If it has not understood the request, it prompts the user to rephrase it, and the process returns to the previous point. If it has understood the request, it explains the route the user needs to follow. Once the interaction has been successful or two consecutive attempts have failed, the robot asks the user if the necessary information has been provided. If yes, the robot dismisses the user. If no, the interaction resumes from the point where the robot asks for the department to reach or the exam to take.

  • OtherInnovative hospital reception service with social robot PEPPER

    The robot PEPPER welcomes the user and asks how it can assist them, stating the following phrase: "Good morning and welcome to INRCA. I am PEPPER and I am here to provide directions to help you reach your desired location within the hospital. Which department do you need to reach or which exam do you need to take? " At this point, the user responds, and the robot, in turn, replies in two possible ways: If it has not understood the request, it prompts the user to rephrase it, and the process returns to the previous point. If it has understood the request, it explains the route the user needs to follow. Once the interaction has been successful or two consecutive attempts have failed, the robot asks the user if the necessary information has been provided. If yes, the robot dismisses the user as follows: "Thank you for your participation. Have a good day." If no, the interaction resumes from the point where the robot asks for the department to reach or the exam to take.

06

What researchers measure

Primary outcomes

  1. perceived quality of the innovative reception service

    The perceived quality will be evaluated by an ad hoc Customer Satisfaction questionnaire. The definition of this indicator is evaluated by quantifying several variables, including: the attention received from the robot in terms of accuracy of the interaction and courtesy (score from 1 - not at all satisfied - to 7 - very satisfied), the clarity and completeness of the information received (score from 1 - not at all satisfied - to 7 - very satisfied), the respect for personal privacy (score from 1 - not at all satisfied - to 7 - very satisfied), the overall satisfaction with the service provided (score from 1 - not at all satisfied - to 7 - very satisfied), and whether the service would be recommended to others (score from 1 - absolutely not - to 7 - definitely yes).

    Time frame: immediately after the intervention

Secondary outcomes

  1. Usability

    The usability will be evaluated by the System Usability Scale (SUS). It consists of a 10-item questionnaire with five response options for respondents, ranging from "Strongly Agree" to "Strongly Disagree." The score for the System Usability Scale (SUS) is calculated by following these steps: * For odd-numbered questions (1, 3, 5, 7, 9), subtract 1 from the user's rating. * For even-numbered questions (2, 4, 6, 8, 10), subtract the user's rating from 5. * Add the new values for all 10 questions. * Multiply this sum by 2.5. This final number gives you a score out of 100. The System Usability Scale (SUS) score, ranging from 0 to 100, is interpreted to indicate the perceived usability of a system. Higher scores suggest better usability. Interpreting SUS Scores: 90-100: exceptionally good usability. 80-89: very good usability 70-79: good usability 60-69: the usability is marginal 50-59: Poor usability 0-49: Extremely poor usability

    Time frame: immediately after the intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2024 (actual). Primary completion is estimated for Jul 2025, 7 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 14, 2025
First posted
Jun 3, 2025
StartActual
Dec 18, 2024
Primary completionEst.
Jul 30, 2025
CompletionEst.
Jul 30, 2025
Last update
Jun 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07002411
Lead sponsor
Istituto Nazionale di Ricovero e Cura per Anziani
Responsible party
Sponsor
First posted
Jun 3, 2025
Start date
Dec 18, 2024
Primary completion
Jul 30, 2025 (estimated)
Completion
Jul 30, 2025 (estimated)
Last update
Jun 3, 2025

Study contacts

Anna Rita Bonfigli
Contact
a.bonfigli@inrca.it
0718003719
Letizia Ferrara, MD
principal investigator · IRCCS INRCA, Ancona, Italy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion